Health

scribd.com/WorldBankPublications - April 2012

Poor people living in slums are at particularly high risk from the impacts of climate change and natural hazards. They live on the most vulnerable lands within cities, typically areas that are deemed undesirable by others and are thus affordable. Residents are exposed to the impacts of landslides, sea-level rise, flooding, and other hazards.

Exposure to risk is exacerbated by overcrowded living conditions, lack of adequate infrastructure and services, unsafe housing, inadequate nutrition, and poor health. These conditions can turn a natural hazard or change in climate into a disaster, and result in the loss of basic services, damage or destruction to homes, loss of livelihoods, malnutrition, disease, disability, and loss of life.

This study analyzes the key challenges facing the urban poor given the risks associated with climate change and disasters, particularly with regard to the delivery of basic services, and identifies strategies and financing opportunities for addressing these risks.

Several key findings emerge from the study and provide guidance for addressing risk:

Photo - Prochymal - osiris.com

submitted by Luis Kun

The New York Times - by Andrew Pollack - May 17, 2012

In a boost for the field of regenerative medicine, a small biotechnology company has received regulatory approval in Canada for what it says is the first manufactured drug based on stem cells.

The company, Osiris Therapeutics of Columbia, Md., said Thursday that Canadian regulators had approved its drug Prochymal, to treat children suffering from graft-versus-host disease, a potentially deadly complication of bone marrow transplantation.

submitted by Luis Kun

Homeland Security News Wire - May 9, 2012

Each year, seasonal influenza causes serious illnesses in three to five million people and 200,000 to 500,000 deaths; university of British Columbia researchers have found a potential way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations

Each year, seasonal influenza causes serious illnesses in three to five million people and 200,000 to 500,000 deaths. The 2009 H1N1 pandemic killed more than 14,000 people worldwide. Meanwhile, public health and bioterrorism concerns are heightened by new mutations of the H5N1 bird flu virus, published last week by the journal Nature, that could facilitate infection among mammals and humans.

Led by Professor John Schrader, Canada Research Chair in Immunology and director of the University of British Columbia’s (UBC) Biomedical Research Center, the research team found that the 2009 H1N1 swine flu vaccine triggers antibodies that protect against many influenza viruses, including the lethal avian H5N1 bird flu strain.

The rash as seen on the hands and feet caused by the mystery "infection" - Photo credit: Saigon Giai Phong

google.com / News - AFP - April 23, 2012

HANOI, Vietnam — The World Health Organisation said Monday it was "concerned" about an outbreak of a mysterious skin disease in central Vietnam which has killed 19 people, mostly children.

More than 170 people have fallen ill with the unidentified illness, which causes stiffness in the limbs and ulcers on victims' hands and feet that look like severe burns.

"We are concerned about this. WHO is very aware of this case," said Wu Guogao, the organisation's chief officer in Hanoi, adding Vietnam had not asked for help with an investigation into the outbreak.

The WHO has not been given access to any official reports on the issue.

(READ COMPLETE ARTICLE)